Doctor profile · Federal record
Dr. Ellison Smith, M.D.
Rheumatology Physician (CMS: Rheumatology) · Asheville, NC
- NPI 1538123989
- Accepts Medicare
- MIPS 92.1 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4 Vanderbilt Park Dr, Suite 200
Asheville, NC 288031700
(828) 258-9533
fax (828) 253-4434
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- May 28, 2013
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- North Carolina #9900353
- Medicaid
- NC #891194N
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538123989. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
166,502
Distinct HCPCS
10
Medicare allowed
$2,248,809
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 59,200 | 29 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 34,040 | 21 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 23,550 | 44 | $13 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 14,280 | 24 | $10 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,300 | 35 | $42 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 7,290 | 20 | $37 | |
J0897 |
Injection, denosumab, 1 mg | 5,640 | 73 | $23 | |
J9312 |
Injection, rituximab, 10 mg | 2,650 | 17 | $75 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 729 | 286 | $8 | |
82565 |
Blood creatinine level | 727 | 300 | $5 |
In context: peer comparison
Among 4 peers in Asheville Rheumatology Physician, average services per provider: 2,848. This provider delivers 58× the peer median.Open Payments
Industry payments received
All-time total
$214
Transactions
10
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $74.15 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $46.71 | |
| Abbvie INC. | 2 | $38.06 | |
| Celgene Corporation | 1 | $23.84 | |
| Amgen INC. | 1 | $16.27 | |
| Pfizer INC. | 1 | $14.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,485
Patients
578
Total drug cost
$2,792,024
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 625 | 155 | $38,422 |
| Methotrexate (Methotrexate Sodium) | Brand | 546 | 132 | $18,680 |
| Prednisone | Generic | 227 | 78 | $2,323 |
| Sulfasalazine | Generic | 158 | 39 | $5,670 |
| Alendronate Sodium | Generic | 137 | 45 | $1,118 |
| Leflunomide | Generic | 98 | 25 | $5,773 |
| Enbrel Sureclick (Etanercept) | Brand | 97 | 11 | $860,141 |
| Humira(Cf) Pen (Adalimumab) | Brand | 89 | 0 | $1,012,249 |
| Duloxetine Hcl | Generic | 88 | 20 | $1,960 |
| Meloxicam | Generic | 75 | 24 | $624 |
Frequently asked questions
What is Dr. Ellison Smith's medical specialty?
Dr. Ellison Smith practices Rheumatology Physician in Asheville, NC.
Where does Dr. Ellison Smith practice?
Dr. Ellison Smith practices at 4 Vanderbilt Park Dr, Asheville, NC 288031700. Office phone: 8282589533.
What is Dr. Ellison Smith's NPI?
Dr. Ellison Smith's National Provider Identifier (NPI) is 1538123989, issued by NPPES.
Does Dr. Ellison Smith accept Medicare assignment?
Yes. Dr. Ellison Smith accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ellison Smith commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.